Amit Khandhar
Director of Formulations HDT Bio
Seminars
Thursday 1st October 2026
Panel Discussion: Scaling LNP Workflows from Discovery to GMP and Beyond: Bridging Throughput, Robustness & Commercial Readiness
1:40 pm
Key questions include:
- How are teams successfully translating high-throughput, discovery-stage LNP workflows into robust, GMP-ready processes without compromising product quality?
- Where do current LNP workflows break when moving from preclinical into clinical and commercial scale – and how can these gaps be addressed early?
- What needs to change today to ensure LNP platforms remain scalable, reproducible, and cost-effective as products move toward global commercial supply?
Wednesday 30th September 2026
Enabling Safe & Effective Delivery of Self-Amplifying RNA – Overcoming Formulation & CMC Challenges from Preclinical to Clinical
11:30 am
- Understanding how the unique biology of self-amplifying RNA drives distinct delivery requirements, and why conventional LNP approaches may not directly translate
- Exploring tissue-localized formulation strategies to optimize potency, dose efficiency and clinical performance of saRNA therapeutics and vaccines
- Overview of clinical data and platform insights into CMC readiness, including how to navigate manufacturing complexity and leverage early clinical data to inform scalable delivery approaches
